Medical management of Crohn’s disease: state of the art and future perspectives
Over the past decade, the improvement in the understanding of the molecular mechanisms of Crohn’s disease (CD) led to the development of more targeted therapies, including biologics - i.e. monoclonal antibodies that selectively block key mediators of inflammation - and novel small molecule drugs -...
Main Author: | Fabio Salvatore Macaluso |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-09-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | https://www.italjmed.org/index.php/ijm/article/view/1194 |
Similar Items
-
Introduction of clinical guidelines for the diagnosis and treatment of osteoarthrosis: results of a cluster randomized trial
by: Dmitri Mikhailovich Maksimov, et al.
Published: (2012-08-01) -
Small molecule drug development for rare genodermatoses – evaluation of the current status in epidermolysis bullosa
by: Verena Wally, et al.
Published: (2020-10-01) -
Challenges and guidelines for clinical trial of herbal drugs
by: Abida Parveen, et al.
Published: (2015-01-01) -
Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01) -
DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)